11thestate
Posted - 6 days ago
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 1 week ago
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 11/27/24
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 11/20/24
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 1 month ago
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 1 month ago
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 10/30/24
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 2 months ago
$ADMS agreed to settle $4.65M with investors to end claims that it overstated the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 2 months ago
$ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. Even if you missed the deadline, if you bought between August 08, 2017, and March 04, 2019, you can file for a payment here: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 09/24/24
$ADMS agreed to settle $4.65M with investors to end claims over overstating the prospects of its lead product, GOCOVRI. Even if the deadline has passed, you can still file for payment if you bought $ADMS between August 08, 2017, and March 04, 2019: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 4 months ago
$ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. You can check if you are eligible and file for the payment here: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 07/25/24
Adamas $ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. Check if you are eligible and apply for a payout: https://11thestate.com/cases/adamas-shareholder-settlement?utm_source=stocktwits&utm_campaign=feed&utm_medium=ADMS
11thestate
Posted - 07/24/24
$ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. You can check if you are eligible and file for the payment here: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 5 months ago
$ADMS has agreed to settle $4.65 million with investors to resolve claims regarding the overstatement of their lead product's prospects: https://11thestate.com/cases/adamas-shareholder-settlement FAQ for the settlement: 1. Do you need to sell/lose my shares to get this settlement? - No, if you have purchased during the class period, you are eligible. 2. How much money do I get per share? - The average sum is $0.27 per share, but usually, only 25% of all shareholders claim it, so you can get 4x more than this. 3. Who can claim this settlement? - Anyone who purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive. 4. How long does the payout process take? - The entire process usually takes 4 to 9 months after the claim deadline. But the exact timing depends on the court and settlement administration. To file a claim: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 5 months ago
$ADMS has agreed to settle $4.65 million with investors to resolve claims regarding the overstatement of their lead product's prospects. You can check if you are eligible and file for the payment here: https://11thestate.com/cases/adamas-shareholder-settlement
11thestate
Posted - 5 months ago
$ADMS agrees to pay $4.65M to investors to settle claims of overstating their lead product's prospects. File for the payout: https://11thestate.com/cases/adamas-shareholder-settlement?utm_source=stocktwits&utm_medium=notifications&utm_campaign=elms Who is eligible: “All persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive, and were damaged thereby.”
11thestate
Posted - 6 months ago
$ADMS agrees to pay $4.65M to investors to settle claims of overstating their lead product's prospects. You can file for the payment here: https://11thestate.com/cases/adamas-shareholder-settlement Who is eligible: “All persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive, and were damaged thereby.”
11thestate
Posted - 8 months ago
$ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. Claim submission info and details:https://11thestate.com/cases/adamas-shareholder-settlement
ca_rott1487
Posted - 8 months ago
$ADMS has agreed to settle $4.65M with investors to resolve claims regarding the overstatement of their lead product's prospects. Claim submission info and details: https://11thestate.com/cases/adamas-shareholder-settlement Who is eligible to get a payout? All persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive, and were damaged thereby.
Stan_Vick
Posted - 9 months ago
Adamas was acquired by $SUPN in 2021. How do investors in $ADMS find out about settlement entitled to them? @11thestate
Stan_Vick
Posted - 9 months ago
🎉 Adamas Pharma agreed to settle $4.65 million with investors to resolve claims for the overstatement of $ADMS lead product's prospects => https://11thestate.com/cases/adamas-shareholder-settlement
ca_rott1487
Posted - 9 months ago
$SUPN $ADMS has agreed to settle $4.65M to resolve claims regarding the overstatement of their lead product's prospects. case page: https://11thestate.com/cases/adamas-shareholder-settlement
Happy_Analyzer
Posted - 1 year ago
$LIXT wow, good job shorty $ADMS $MSGM still on watch
